MSK-MET_set1&2
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25000 patients
Pan-cancer cohort including genomic and clinical data from more than 25,000 patients (MSK-MET) used to identify associations between genomic alterations and patterns of metastatic dissemination across 50 tumor types
Pan-cancer cohort including genomic and clinical data from more than 25,000 patients (MSK-MET) used to identify associations between genomic alterations and patterns of metastatic dissemination across 50 tumor types